These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 5038945

  • 1. [Bronchodilator response in asthma. Effects of salbutamol].
    Goldman E, Puy RJ, Roncoroni AJ, Badaracco V.
    Medicina (B Aires); 1972; 32(2):100-10. PubMed ID: 5038945
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Function of the respiratory airways following inhalation of bronchodilator agents in patients with asthma].
    Zapletal A, Samánek M, Paul T, Rakowská S, Copová M, Suková B.
    Cas Lek Cesk; 1975 May 23; 114(21):644-50. PubMed ID: 1131849
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Salbutamol as a beta-adrenergic stimulator in bronchospastic pulmonary conditions].
    Dano P, Falholt W.
    Ugeskr Laeger; 1971 Apr 16; 133(15):685-8. PubMed ID: 4396922
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pirbuterol versus orciprenaline aerosols in the treatment of bronchial asthma.
    Beumer HM.
    Int J Clin Pharmacol Ther Toxicol; 1983 Mar 16; 21(3):147-66. PubMed ID: 6343262
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A new bronchodilator, hexoprenaline, in obstructive pulmonary disease.
    van As A, Benjamin C, Stern JD.
    Scand J Respir Dis; 1973 Mar 16; 54(1):28-37. PubMed ID: 4690403
    [No Abstract] [Full Text] [Related]

  • 13. Double-blind comparison of isoprenaline, orciprenaline and salbutamol aerosols in patients with asthma.
    Tala E, Kellomäki L, Pylkäs A.
    Postgrad Med J; 1971 Mar 16; 47():Suppl:61-3. PubMed ID: 4929395
    [No Abstract] [Full Text] [Related]

  • 14. The bronchodilator effects of orciprenaline and salbutamol: a double-blind study.
    Racoveanu C, Stanescu DC, Manicatide M, Stroescu V.
    Bull Physiopathol Respir (Nancy); 1970 Mar 16; 6(4):809-18. PubMed ID: 4940888
    [No Abstract] [Full Text] [Related]

  • 15. [Orciprenaline: an "old" bronchodilator still valid. Comparative study of the bronchodilator effect of orciprenaline and salbutamol in patients with obstructive type respiratory dysfunctional syndrome].
    Petraglia A, De Cataldis G, Tarantino O, Materazzi F.
    Clin Ter; 1976 Dec 31; 79(6):555-62. PubMed ID: 1009760
    [No Abstract] [Full Text] [Related]

  • 16. Comparative study of a new beta-adrenergic stimulant in asthma: salbutamol.
    Gayrard P, Orehek J, Charpin J.
    Postgrad Med J; 1971 Mar 31; 47():Suppl:46-50. PubMed ID: 4396720
    [No Abstract] [Full Text] [Related]

  • 17. Mortality from asthma and bronchodilator aerosols.
    Campbell AH.
    Med J Aust; 1976 Mar 20; 1(12):386-91. PubMed ID: 1272120
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A crossover comparison of isoproterenol, metaproterenol and isoetharine by spirometric determinations.
    Howard LA, Coleman M.
    Ann Allergy; 1967 Sep 20; 25(9):512-9. PubMed ID: 4861327
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical trial of Alupent (Th. 152) in aerosol applicator in spasmodic respiratory syndromes].
    Ollagnier C, Vallon C.
    Lyon Med; 1968 Oct 06; 220(40):787-90. PubMed ID: 5741167
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.